Bill Text: IL HB3710 | 2023-2024 | 103rd General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Reinserts the provisions of the introduced bill with the following changes. Changes the short title of the Act to the Alternative Protein Innovation Task Force Act. Changes the name of the Protein Innovation Commission to the Alternative Protein Innovation Task Force. Adds members to the Task Force. Makes changes concerning the duties of the Task Force and the report it is to prepare. Makes other changes. Effective immediately.

Spectrum: Partisan Bill (Democrat 7-0)

Status: (Passed) 2023-08-11 - Public Act . . . . . . . . . 103-0543 [HB3710 Detail]

Download: Illinois-2023-HB3710-Introduced.html

---

103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3710 Introduced , by Rep. Lakesia Collins SYNOPSIS AS INTRODUCED:
New Act
Creates the Protein Innovation Commission Act. Creates the Protein Innovation Commission for the purposes of making an investigation and study relative to alternative proteins and to develop a master plan of recommendations for fostering the appropriate expansion of protein innovation and the alternative protein industry in the State. Provides specifications on what the Commission should examine. Provides for membership, appointment, and meetings of the Commission. Provides that the Commission shall study and analyze the potential benefits of alternative proteins and shall address specified items in its report. Provides that the Commission shall submit a report of its findings and recommendations to the General Assembly, together with drafts of legislation necessary to carry out those recommendations, not later than December 31, 2023. Effective immediately.
LRB103 27320 CPF 53691 b
A BILL FOR
HB3710 LRB103 27320 CPF 53691 b
AN ACT concerning health.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 1. Short title. This Act may be cited as the
Protein Innovation Commission Act.
Section 5. Definitions. As used in this Act:
"Alternative proteins" means proteins created from
plant-based, fermented, cell cultured inputs and processes to
create foods that share sensory characteristics consistent
with conventional meat and dairy.
"Cultivated meat" refers to meat that is directly produced
from animal cells using a cell cultivation process made with
bioreactors.
"Fermented proteins" refers to proteins made from
traditional fermentation, biomass fermentation, and precision
fermentation.
"Plant-based protein" refers to proteins produced directly
from plants, composed of protein, fat, vitamins, minerals, and
water.
Section 10. Protein Innovation Commission. The Protein
Innovation Commission is established for the purposes of
making an investigation and study relative to alternative

HB3710 - 2 - LRB103 27320 CPF 53691 b
proteins and to develop a master plan of recommendations for
fostering the appropriate expansion of protein innovation and
the alternative protein industry in the State. The Commission
shall study how the State can best support the growing
alternative protein industry in the State. The Commission
shall examine: (i) the potential economic development benefits
and job creation potential of the plant-based, cultivated, and
fermented meat industries in the State; (ii) identify the
environmental benefits, including the reduced land use,
reduced deforestation, and reduced greenhouse gas emissions,
of alternative proteins compared to conventional meat and
dairy products in the State; (iii) examine how alternative
proteins can strengthen the State's food resiliency; (iv)
assess how alternative proteins can improve individual and
public health and combat antibiotic resistance; and (v)
identify ways the State can foster the growth of the emerging
alternative protein industry, including by reviewing past
efforts made to support the broader biotech and life science
industries.
Section 15. Membership; appointments; meeting.
(a) The Protein Innovation Commission shall consist of the
following members:
(1) 3 members of the Senate, 2 of whom shall be
appointed by the President of the Senate and one of whom
shall be appointed by the Minority Leader of the Senate;

HB3710 - 3 - LRB103 27320 CPF 53691 b
(2) 3 members of the House of Representatives, 2 of
whom shall be appointed by the Speaker of the House of
Representatives and one of whom shall be appointed by the
Minority Leader of the House of Representatives;
(3) the Secretary of Commerce and Economic Opportunity
or the Secretary's designee; and
(4) 6 members appointed by the Governor. Of the
members appointed by the Governor: 2 members who are
engaged in academic or scientific research on alternative
protein development at a State college or university; one
member who is engaged in the private sector research and
development of alternative proteins; one member who is an
expert in food security issues; and one member who is the
president of the Illinois Biotechnology Industry
Organization or the organization's designee.
(b) The President of the Senate and Speaker of the House of
Representatives shall each designate one of the President's
and the Speaker's appointments to serve as co-chair of the
Commission.
(c) Members shall not receive compensation for the
members' services.
(d) All appointments shall be made not later than 30 days
after the effective date of this Act.
(e) The co-chairs shall schedule no fewer than 4 meetings
of the Commission, including no fewer than one public hearing.
The co-chairs shall convene the first meeting of the

HB3710 - 4 - LRB103 27320 CPF 53691 b
Commission within 60 days after the effective date of this
Act.
Section 20. Commission report.
(a) The Commission shall study and analyze the potential
benefits of alternative proteins and shall address in its
report:
(1) the job growth potential of the alternative
protein industry in the State, as demand for meat
continues to grow;
(2) how plant-based, fermented, and cultivated meat
can reduce the State's greenhouse gas emissions and yield
other environmental benefits;
(3) how the State can support new and emerging
companies in this sector and what pressing challenges the
industry currently faces;
(4) policy options the State can take to address the
alternative protein industry;
(5) how to facilitate the growth of the alternative
protein industry; and
(6) any other topic that the Commission may choose to
examine in relation to alternative proteins.
(b) The Commission shall submit a report of its findings
and recommendations to the General Assembly, together with
drafts of proposed legislation necessary to carry out those
recommendations, not later than December 31, 2023.

HB3710 - 5 - LRB103 27320 CPF 53691 b
Section 99. Effective date. This Act takes effect upon
becoming law.